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Abstract Background and aim: Pulmonary hypertension (PH) determines various
adaptive changes in right ventricular (RV) geometry which may progressively lead
to hypertrophy, mechanical dysfunction and dilatation with pump failure. Right
atrium (RA) is theoretically involved in this physiopathological process, but its role
has never been investigated. We hypothesized that RA increases volume and func-
tion to assist RV during the chronic pressure overload exposition due to PH.
Methods: We prospectively enrolled 66 consecutive patients referred to our echo-
lab with a diagnosis of PH [defined as pulmonary artery systolic pressure (PASP)
>30 mmHg] associated with disorders of the respiratory system and/or hypoxemia
and normal RV systolic function. Ejection force was taken up as index of RA systolic
function and calculated according to the Manning’s formula. Thirty-three healthy
subjects for whom PH was definitely excluded by echoDoppler evaluation were used
as controls.
Results: PASP was 42  10 and 20  8 mmHg in PH patients and controls, respec-
tively; p ¼ 0.00001). In comparison with controls, PH patients exhibited higher RA
volume (37  13 vs 32  13 ml, p ¼ 0.04) and RA ejection force (6.7  3.0 vs
3.5  1.8 Kdynes, p ¼ 0.00001). Both variables were positively related to PASP
(r ¼ 0.23 and 0.48, p ¼ 0.02 and 0.00001, respectively).
* Corresponding author. Tel.: þ39 461 916 000; fax: þ39 461 916 874.
E-mail address: gcioffi@villabiancatrento.it (G. Cioffi).1525-2167/$32 ª 2006 Published by Elsevier Ltd on behalf of The European Society of Cardiology.
doi:10.1016/j.euje.2006.06.006
Right atrium in pulmonary hypertension 323Conclusions: In patients with chronic PH, RA size and systolic function significantly
increase and parallel signs of activation of the Frank-Starling mechanism in both
right chambers. The magnitude of these phenomena is positively related to PASP
levels.
ª 2006 Published by Elsevier Ltd on behalf of The European Society of Cardiology. at FACO
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 Introduction
Chronic pulmonary hypertension (PH) determines
various adaptive changes in right ventricular (RV)
geometry which can progressively result in hyper-
trophy, mechanical dysfunction and dilatation with
pump failure. Right atrium is theoretically involved
in this pathophysiological process, but its role has
never been investigated. What the sonographers
classically describe in patients with chronic PH is
the final echocardiographic feature of a marked
enlarged right atrium which usually parallels RV
dilatation and systolic dysfunction, and leads to
chronic atrial fibrillation. However, it is not known
when changes in right atrial (RA) size arise during
the natural history of chronic PH and whether
these changes come up together with increase in
RA performance. In patients with systemic arterial
hypertension and normal left ventricular (LV)
systolic function, as well as in other models of LV
overload,1,2 an early increase in left atrial size and
function has been shown to be a mechanism coun-
terbalancing impairment of LV filling and the
progression of LV diastolic dysfunction.3,4 Simi-
larly, we hypothesize that right atrium initiates
to increase volume and systolic function prior to
the development of RV dilatation and systolic dys-
function for assisting the right ventricle during the
chronic pressure overload exposition due to PH.
Accordingly, the purpose of this study was to assess
RA size and systolic function in patients with PH
and normal RV systolic function, and define the
relations of RA function to clinical, echocardio-
graphic and hemodynamic parameters in this group
of patients.
Methods
Candidates for this study were subjects >18 years
of age in stable sinus rhythm who were addressed
from their General Practitioners to our laboratory
to perform a standard transthoracic echocardiog-
raphy. The echocardiograms were required as
part of the normal clinical evaluation for clarifying
the etiology of various symptoms such as breath-
less or asthenia or reduction in functional capacityto exclude cardiovascular and pulmonary diseases.
We selected patients with PH associated with dis-
orders of the respiratory system and/or hypoxemia
but normal RV systolic function (as defined below).
Diagnosis of pulmonary disease and/or hypoxemia
was confirmed on the basis of anamnesis, clinical
examination, plain chest radiography and lung
function testing. Exclusion criteria were: a possible
diagnosis of PH resulting from thrombotic and/or
embolic disease, the presence of RV and/or LV
systolic dysfunction, more than mild LV diastolic
dysfunction,5 RV and LV wall motion abnormalities
and or dilatation, more than mild valvular regurgi-
tation (defined as maximal regurgitant area
<2.5 cm2 measured by echo-Color-Doppler tech-
nique) or any grade of valvular stenosis, docu-
mented episodes of sustained atrial arrhythmias
occurred within one month before echocardio-
gram. Patients taking medications to prevent
recurrences of atrial arrhythmias were also not
eligible. New York Heart Association classification
was used for the functional assessment of the study
patients.
Echocardiography
Standard transthoracic echocardiographic studies
were performed in a dimly light room with all
patients in partial left decubitus position with
a Megas Esaote Biomedica machine (Florence,
Italy) equipped using a 2.5e3.5 MHz annular-array
transducer and a second harmonic application.
They were recorded on Super-VHS Panasonic
videotape for subsequent analysis. LV chamber
dimensions, septum and posterior wall thickness
were measured according to the American Society
of Echocardiography,6 using M-mode tracings. The
Penn Convention was used only to calculate LV
mass from 2D-guided M-mode echocardiograms.7
LV mass was therefore normalized for height to
the 2.7 power8 and LV hypertrophy was defined
as LV mass >51 g/m2.7.8 Maximal RA volume and
LV end-systolic and diastolic volumes were calcu-
lated by 2D-mode apical 2 and 4-chamber views
using the area e length method.9,10 RA ejection
force was taken up as index of RA systolic function
representing the estimation of the force exerted
324 G. Cioffi et al.
 at FACO
LTA' ING
EG
NERIA NAPO
LI - BIBLIO
TECA CENTRALE on Novem
ber 26, 2010
ejechocard.oxfordjournals.org
D
ow
nloaded from
 by the contracting right atrium to accelerate the
blood into the right ventricle. It was calculated
according to the formula previously used for left
atrium by Manning et al.,11 with calculation of
the tricuspid valve area from the tricuspid diame-
ter, assuming a circular geometry. The formula we
used was:
RA ejection force¼ 0:5 r tricuspid orifice area
 ðpeak A velocityÞ2
whereas r was the density of blood (1.06 g/cm3)
and A was the wave velocity passing through the
tricuspid orifice during the accelerative phase of
RA systole (peak late diastolic flow velocity of
transtricuspid flow).
To optimally relate measurements of RV di-
astolic trans-tricuspid flow velocity to volume
flow, trans-tricuspid flow velocities were recorded
by use of pulsed-wave Doppler scanning from the
apical 4-chamber view, positioning the sample
volume between the tricuspid leaflets at the mid-
dle of the tricuspid annulus, the diameter of which
varies modestly during diastole, as opposed to the
leaflet tips, where the orifice shows substantial
variation through the cardiac cycle: peak early
diastolic flow velocity (E), peak late diastolic flow
velocity (A) and their ratio (E/A), E deceleration
time and E deceleration rate were obtained at the
end of inspiration during a short period of apnea
from average of 5 consecutive cycles and mea-
sured using the leading-edge convention.12 We also
estimated the RA end-diastolic stress multiplying
RA ejection force  RA volume. Such index is actu-
ally a measure of wall strain which, however, can
be assumed approximately as a measure of wall
stress considering the thinness of atrial walls, the
inter-individual variability of which is trivial and
has no influence on the calculation of these hemo-
dynamic variables.
Pulmonary artery systolic pressure (e-PASP) was
non-invasively estimated with echo-Doppler
techniques from systolic RV-RA gradient (peak
instantaneous systolic pressure drop from right
ventricle to right atrium) and RA pressure. RV-RA
gradient was estimated by the peak velocity of the
tricuspid regurgitant flow signal using the simpli-
fied Bernoulli equation (continuous-wave Doppler
at the apical 4-chamber view), while RA pressure
was obtained calculating the means of the inferior
vena cava collapsibility index measured in the
subcostal view (2D and M-Mode techniques).13 RV
systolic function was assessed measuring both per-
cent fractional area change (FAC) using 2D-mode
technique14 and tricuspid annular plane systolicexcursion (TAPSE) using M-mode technique15: RV
end-diastolic and end-systolic area were measured
from the 4 chamber apical view and FAC was
estimated as end-diastolice end-systolic area/end-
diastolic area  100. TAPSE was measured posi-
tioning the M-mode cursor at the junction of the
tricuspid valve plane with the RV free wall and
was defined as the distance in the displacement
of the tricuspid valve plane from end-diastole to
end-systole. RV end-diastolic diameters (measured
both at the inflow tract from apical 4-chamber
view using 2D-mode technique and at the outflow
tract from parasternal view using M-mode tech-
nique) were used as index of RV size.
Control group
Among individuals who referred to our laboratory
for ‘‘asthenia’’, ‘‘palpitations’’ or ‘‘harmless car-
diac murmur’’ with no echocardiographic evidence
of cardiac or valvular disease and with a physiologic
mild tricuspid regurgitation and normal e-PASP,
thirty-three subjects matched for age and gender
were selected and used as controls. Echocardio-
graphic parameters resulting from these patients
were used to identify the cut-off of abnormality
for the study population which had been a priori
defined as values exceeding the mean  2 stan-
dard deviations of the normal distribution of
control population.
Echo measurements were obtained by video-
tape analysis without the knowledge of categori-
zation as PH patients or controls. Reproducibility
of M-Mode, 2D-Mode and pulsed-wave Doppler
echocardiographic measurements from our labora-
tories has been previously reported.1,4,16,17
The protocol of the present study was approved
by the local institutional review board and written
informed consent was obtained from all recruited
patients.
Definitions and statistical analysis
In most of previous studies, PH was roughly and
rigorously defined as values of e-PASP exceeding
30 mmHg. Considering the observations of McQuil-
lan et al.18 who showed a close independent asso-
ciation between age and e-PAPS among normal
individuals with an average increase in e-PASP
of y1 mmHg per decade attributed to an higher
vascular resistance and lower LV compliance with
aging, in our study PAH was taken to be present
if e-PASP was >32 mmHg at echocardiographic
evaluation. On the basis of parameters resulting
from the control group, RV systolic dysfunction
Right atrium in pulmonary hypertension 325
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 was diagnosed when TAPSE was <16 mm and/or
FAC was <35%, RV dilatation was identified in
case RV end-diastolic diameter was greater than
46 mm (inflow tract) or 24 mm (outflow tract), LV
systolic dysfunction was defined as LV ejection
fraction <50%. These cut-off points were used
for an accurate patient’s selection into this study.
K-means clustering analysis was performed to split
the study population into subgroups by maximizing
between-cluster variation in baseline e-PASP.
Two distinct clusters were identified (<42 mmHg
and 42 mmHg) and compared using Euclidean
distance metric. These clusters represented two
subgroups of patients defined as ‘‘mild’’ and
‘‘moderate-severe PH’’, who were studied in a
separate analysis. ‘‘Supernormal RA ejection force’’
was identified when values of RA ejection force
were greater than the mean value þ 2 standard
deviation of the mean of controls.
Data are reported as mean value  1 standard
deviation. Unpaired Student’s test and c2 statistics
were used for descriptive statistics. Between-
group comparisons of continuous and normally dis-
tributed variables were performed by the analysis
of variance (ANOVA). Least squares simple regres-
sion analyses were used to investigate the relation
of RA ejection force and maximal RA volume to the
clinical and echocardiographic parameters consid-
ered in this study, and to identify factors associ-
ated with high RA ejection force and size.
Therefore, the independent relation of the factors
significantly related to RA ejection force and max-
imal RA volume at the univariate analysis was
investigated through multiple regression analyses.
A two-tailed value of p < 0.05 was considered as
statistically significant.
Results
Recruitment period lasted from October 2004 to
March 2005. During this period, 66 subjects with PH
met the enrolment criteria defined in the study
protocol. Their mean age was 75  9 years, the
cause of PH was chronic obstructive pulmonary dis-
ease in 52 patients (79%), interstitial lung disease
in 7 (10%), alveolar hypoventilation disorders in 4
(6%), chronic inflammatory conditions in 3 (5%).
The main clinical and echocardiographic charac-
teristics of these subjects were compared with
those of 33 patients selected as controls. Individ-
uals with PH exhibited lower functional class,
greater RV free wall thickness, higher RA size,
ejection force and end-diastolic stress. In particu-
lar, RA ejection force, was about 2-fold higher in
PH patients than controls and such differencewas due to an increase in both tricuspid orifice
area and A wave flow velocity. Even trans-tricuspid
peak E/A ratio was significantly different between
the 2 groups being higher in controls (Table 1).
Right atrial systolic function
The relations of RA ejection force to the clinical
and echocardiographic parameters resulting from
the univariate regression analyses are reported in
the Table 2 (top list). Fig. 1 shows the close rela-
tionship existing between the RA ejection force
and RA end-diastolic stress. To verify whether rela-
tion of RV systolic function with RA ejection force
was independent of confounders, we performed
a multiple regression analysis including both
patients and controls. Such analysis was initially
performed excluding parameters of RV diastolic
function; it revealed that RV systolic function
(valuated with TAPSE) was positively associated
with RA ejection force and this association was
independent of e-PASP (Table 3, top list). These
positive relationships were lost when parameters
of RV diastolic function were tested (Table 4, top
list).
Supernormal RA performance was identified as
values of RA ejection force exceeding 6.7 Kdynes
(the mean value þ 2 standard deviation of the
mean of controls). This condition was detected in
44 of 66 patients with PH (67%) and in 3 of 33 con-
trols (9%, p ¼ 0.00001) (Fig. 2). Considering the
whole study population, patients with supernormal
RA ejection force differed from those with normal
RA ejection force for having a worse NYHA func-
tional class (2.7  0.8 vs 1.9  0.7, p ¼ 0.0001),
higher LV mass (59  18 vs 48  15 g/m2.7, p ¼
0.02), higher e-PASP (48  10 vs 38  12 mmHg,
p ¼ 0.0001), higher RA pressure (5.2  2.0 vs
4.4  1.7, p ¼ 0.04) and RA end-diastolic stress
(345 159 vs 145 80 Kdynes/cm2, p¼ 0.0000001).
All these variables, but RA pressure, remained
significantly higher in patients belonging to the
supernormal RA ejection force group also when
only patients with PH were considered (data not
shown). Parameters of RV systolic function, RV
dimensions and age were similar between the
2 groups.
RA size
Table 2 (bottom list) reports the clinical and echo-
cardiographic parameters significantly related to
maximal RA volume resulting from the univariate
regression analyses. Fig. 3 shows the relation exist-
ing between the maximal RA volume and the
indexes of RV size. Multiple regression analysis
326 G. Cioffi et al.
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 Table 1 Comparison between the main clinical and echocardiographic characteristics of patients with pulmonary
hypertension and controls measured at baseline evaluation
Variables PAH 66 Controls 33 p
Age (years) 75  9 76  8 ns
Men (%) 28 36 ns
NYHA functional class 2.5  0.8 1.5  0.5 0.00001
Systolic arterial blood pressure (mmHg) 136  15 135  16 ns
Diastolic arterial blood pressure (mmHg) 81  5 81  5 ns
Diabetes mellitus (%) 8 4 ns
Systemic arterial hypertension (%) 48 67 ns
Left ventricular ejection fraction (%) 61  7 62  6 ns
Left ventricular mass (gr/h2.7) 52  11 52  18 ns
LV hypertrophy (%) 39 36 ns
Relative wall thickness 0.40  0.06 0.40  0.06 ns
Pulmonary artery systolic pressure (mmHg) 42  10 20  8 0.00001
Right atrial pressure (mmHg) 5.5  2 4.1  2 0.005
RV end-diastolic diameter (inflow tract) (2D-mode) (mm) 38  7 36  5 ns
RV end-diastolic diameter (outflow tract) (M-mode) (mm) 19  5 18  3 ns
RV free wall thickness (mm) 10  3 8  1 0.0001
RV fractional area change (%) 53  10 55  10 ns
TAPSE (tricuspid annular plane systolic escursion) (mm) 27  5 26  4 ns
Peak E wave transtricuspid flow (cm/s) 40  9 37  9 ns
Peak A wave transtricuspid flow (cm/s) 45  10 38  10 0.001
Peak E/A wave ratio 0.88  0.24 1.01  0.28 0.01
Deceleration time E wave transtricuspid flow (msec) 235  68 226  73 ns
Deceleration rate E wave transtricuspid flow (cm/s2) 1.8  0.8 1.9  0.9 ns
Tricuspid orifice area (cm2) 6.2  1.4 4.6  1.3 0.00001
Right atrial maximal volume (ml) 37  13 32  13 0.04
Right atrial ejection force (Kdynes) 6.7  2.7 3.5  1.6 0.00001
Right atrial end-diastolic stress (Kdynes/cm2) 252  147 107  58 0.00001
NYHA: New York Heart Association; RV ¼ right ventricular. NAPO
LI - BIBLIO
TECA CENTRALE on Novem
ber 26, 2010revealed that RA size was positively and indepen-
dently related to greater RV dimension and
increased RV systolic function, while no associa-
tion was found with RA pressure or e-PASP (Table 3,
bottom list). The relationship between maximal
RA volume and RV end-diastolic diameter was
maintained in spite of the effects of parameters
of RV diastolic function (Table 4, bottom list).
Mild and moderate-severe PH
Among 66 patients with PH, 20 (30%) had a mild
increase and 46 (70%) had a moderate-severe
increase in e-PASP (mean 35  4 and 51  8 mmHg,
respectively). These two subgroups of patients
differed for many variables which are listed in the
Table 5. In comparison with controls, patients with
mild PH had similar RA ejection force (3.5  1.6 vs
4.1  2.0 Kdynes) and maximal RA volume (32  13
vs 34  14 ml), while these two variables were sig-
nificantly higher in patients with moderate-severe
PH (7.0  3 Kdynes and 38  14 ml, respectively;p < 0.01 both vs mild PH group and controls). RA
ejection force was independently related in both
groups only to parameters of RV diastolic function.
Similarly, RA size closely correlated to parameters
of diastolic function together with TAPSE in patients
with mild PH, and RV dimensions in moderate-
severe PH (Table 6).
Discussion
When a cardiac chamber is exposed to chronic
pressure and/or volume overload and its diastolic
properties begin to change, the Frank-Starling
mechanism starts working to counterbalance the
increase in pressure resulting in a progressive aug-
mentation in chamber size and performance. This
behaviour, which might be limited by the degree of
diastolic dysfunction,3,4,19,20 has been clearly docu-
mented in various pathophysiological conditions in
both the left ventricle and left atrium, and charac-
terized in patients with aortic valve disease and
systemic arterial hypertension.1,4,21
Right atrium in pulmonary hypertension 327
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 Table 2 List of the clinical and echocardiographic parameters significatively related to the right atrial ejection
force and maximal right atrial volume
r SEE p
Right atrial ejection force
Peak E/A wave ratio transtricuspid flow 0.62 2.1 0.00001
Right atrial end-diastolic stress (Kdyne/cm2) 0.84 1.56 0.0001
Pulmonary artery systolic pressure (mmHg) 0.49 2.5 0.0001
NYHA functional class 0.47 2.6 0.0001
TAPSE (tricuspid annular plane systolic escursion) (mm) 0.31 2.8 0.002
Right atrial pressure (mmHg) 0.26 2.8 0.01
Left ventricular mass (gr/h2.7) 0.21 2.8 0.04
Maximal right atrial volume
Right atrial end-diastolic stress (Kdyne/cm2) 0.60 10.4 0.0001
RV end-diastolic diameter (inflow tract) (2D-mode) 0.41 11.9 0.0001
RV end-diastolic diameter (outflow tract) (M-mode) 0.38 12.1 0.0001
TAPSE (tricuspid annular plane systolic escursion) (mm) 0.36 11.8 0.0003
Deceleration time E wave transtricuspid flow (msec) 0.36 11.0 0.001
Right atrial pressure (mmHg) 0.32 12.2 0.001
Pulmonary artery systolic pressure (mmHg) 0.23 12.7 0.02
Left ventricular mass (gr/h2.7) 0.23 12.9 0.03
NYHA: New York Heart Association; RV: right ventricular.at FACO
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LI - BIIn this study, we sought to assess RA size and
systolic performance and define the relations of RA
function to clinical, echocardiographic and hemo-
dynamic parameters in patients with PH. The RA
size is routinely measured with validated echocar-
diographic methods in patients with PAH and its
enlargement is one of independent predictors of
adverse outcome in the setting of primary PH.22 In
contrast, RA ejection force has never been studied
before despite it provides a relatively simple mea-
sure of RA systolic function and a useful index forBassessing RA contribution to RV diastolic perfor-
mance. For its quantification, we applied the Man-
ning’s formula based on Newtonian mechanics
validated for calculating left atrial ejection force
utilizing two-dimensional and Doppler tech-
niques.11 Describing this method, the authors
underlined that the use of a circular approximation
for the measurement of the mitral orifice (the
shape of which is actually not circular), was
a bias which was maintained constant through
the study. Conversely, the assumption of a circularLIO
TECA CENTRALE on Novem
ber 26, 2010Ri
gh
t a
tri
al
 e
jec
tio
n f
orc
e (
Kd
yn
es)
Right atrial end-diastolic stress (Kdynes/cm2)
8
10
12
14
16
6
4
2
15 23 35 45 55 65 75 85 95 105 205 305 405 505 605 705 805
r = 0.85
p < 0.0000001
SEE = 1.54
Figure 1 Relation between right atrial ejection force (linear scale) and right atrial end-diastolic stress (logarithmic
scale) in the whole study population. Scatter plot of linear correlation and 95% confidence limits are shown.
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 Table 3 Multiple regression analysis testing the independent relation of the variables associated with right atrial
ejection force and maximal right atrial volume which emerged to the univariate analysis (excluding parameters of
RV diastolic function)
Right atrial ejection force Multiple R ¼ 0.55 R2 ¼ 0.30 Intercept ¼  2.7
SEE ¼ 2.4 F ¼ 19.5 p ¼ 0.0001
Variables Coeff. b p
Pulmonary artery systolic pressure (mmHg) 0.45 0.0001
TAPSE (tricuspid annular plane systolic escursion) (mm) 0.29 0.001
Maximal right atrial volume Multiple R ¼ 0.66 R2 ¼ 0.44 Intercept ¼  35.5
SEE ¼ 9.9 F ¼ 11.3 p ¼ 0.0001
Variables Coeff. b p
RV end-diastolic diameter (outflow tract) (M-mode) 0.34 0.0001
RV end-diastolic diameter (inflow tract) (2D-mode) 0.29 0.001
TAPSE (tricuspid annular plane systolic escursion) (mm) 0.22 0.01
RV ¼ right ventricular. at FACO
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so that the measurement of tricuspid orifice area
and consequently RA ejection force should theo-
retically be more accurate than the mitral orifice
area and left atrial ejection force measured using
the initial Manning’s assumption.
In the present study, realized in a clinical set-
ting, we found out that the Frank-Starling mecha-
nism operates also in the right atrium of patients
suffering from chronic PH. For this investigation,
a homogeneous group of elderly patients with
chronic pulmonary disorders (obstructive pulmo-
nary disease was highly prevalent) was accurately
studied with clinical and echocardiographic evalu-
ations. Compared to controls, they had a significant
increase in RA size, RA end-diastolic stress and
RA systolic function, all changes that increased
with increasing severity of PH. It is also of note
that these changes have been shown in patients
with normal RV dimension and RV systolicEfunction, so that they could be considered an
early warning sign concerning the negative in-
teraction between hemodynamic and right-sided
structural changes in chronic PH. Our analysis
indicated that an increase in RA performance was
systematic in PH patients and a supernormal RA
ejection force was found in a large part of them.
This phenomenon had an expected significant
positive relationship with RV systolic function
and this link was independent of e-PASP, indicat-
ing that a higher RA effort is required for those
patients having a right ventricle solicited to
compensate the increased end-systolic stress
caused by PH throughout recruitment of Starling
forces, allowing preservation of RV function.
Since the RA myocardium is particularly thin and
inclined to respond with dilatation rather than
hypertrophy to overload, this higher effort in-
exorably leads to higher RA diastolic strain and
stress with increase in RA preload.CA CENTRALE on Novem
ber 26, 2010Table 4 Multiple regression analysis applied on the whole study population testing the independent relation of
the variables associated with right atrial ejection force and maximal right atrial volume which emerged to the
univariate analysis (including parameters of RV diastolic function)
Right atrial ejection force Multiple R ¼ 0.91 R2 ¼ 0.82 Intercept ¼ 5.8
SEE ¼ 1.2 F ¼ 106.5 p ¼ 0.00001
Variables Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.68 0.00001
Peak E/A wave ratio transtricuspid flow 0.45 0.00001
Deceleration rate E wave transtricuspid
flow (msec)
0.20 0.0009
Maximal right atrial volume Multiple R ¼ 0.84 R2 ¼ 0.70 Intercept ¼  27.9
SEE ¼ 7.2 F ¼ 36.8 p ¼ 0.00001
Variables Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.67 0.00001
RV end-diastolic diameter (outflow tract) (M-mode) 0.35 0.00001
Peak E/A wave ratio transtricuspid flow 0.31 0.0001
RV end-diastolic diameter (inflow tract) (2D-mode) 0.27 0.0004
RV ¼ right ventricular.
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Figure 2 Bland-Altman plot showing the deviation of values of right atrial ejection force measured in the patients
with pulmonary hypertension (white circles) from the mean value measured in the controls (black circles). The hor-
izontal lines indicate the mean value of right atrial ejection force measured in controls (central line) and 1 and 2 stan-
dard deviations of this mean (upper and lower dashed lines). Three of 33 controls (9%) and 44 of 66 patients with
pulmonary hypertension (67%) had supernormal right atrial ejection force defined as value exceeding 6.7 Kdynes. at FACO
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PH patients and closely associated with RV di-
mension together with parameters of RV function.
Thus, the augmentation in RA size and function
may be interpreted as the two faces of a same coin
representing two early compensatory mechanisms
which develop together with an initial increase in
RV systolic function, the first one activated pro-
portionally to the degree of RV volume overload,
the second one according to the degree of RV
pressure overload both caused by PH. The primum movens of this pathophysiological process, however,
remains the changes in RV geometry, and particu-
larly, in RV diastolic properties as a consequence
of PH. The rise in systolic RV and RA performance
may be interpreted as purely epi-phenomena
which constantly follow RV remodelling, RV im-
paired relaxation (expressed by lower peak E/A
wave ratio of trans-tricuspid flow) and herald in-
crease in RA stress and dilatation. Thus, the sce-
nario emerging from these findings is consistent
with a general activation of the Starling forces inBIBLIO
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Figure 3 Relation between maximal right atrial volume (ml) and right ventricular diastolic diameters measured at
the inflow tract from apical 4-chamber view using 2D-mode technique (left panel) and at the outflow tract from para-
sternal view using M-mode technique (right panel). Scatter plot of linear correlation and 95% confidence limits are
shown.
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nloaTable 5 Comparison between patients with mild ad moderate-severe pulmonary hypertension
Variables Mild PAH 20 Moderate-severe PAH 46 p
NYHA functional class 1.8  0.7 2.7  0.8 0.00001
Pulmonary artery systolic pressure (mmHg) 35  4 51  8 0.00001
RV end-diastolic diameter (inflow tract) (2D-mode) (mm) 35  7 39  5 0.04
Peak A wave transtricuspid flow (cm/s) 38  8 46  10 0.004
Peak E/A wave ratio 1.04  0.2 0.84  0.2 0.004
Right atrial ejection force (Kdynes) 4.1  2 7.0  3 0.0001
List of variables which were statistically different between the 2 groups. at FACO
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 the right heart, to face with the increased RV end-
systolic stress and stiffness caused by PH, in a con-
text of patients without substantial RV dilatation
or RV systolic dysfunction. Right atrium increases
its ejection force thanks to the increased preload
and, in turn, increases late RV filling pressure,
which can recruit Starling forces to sustain RV
systolic function.
Study limitations
Our investigation presents some limitations. We do
not have invasive hemodynamic data to measuredirectly RV filling pressure and end-diastolic pres-
sure. However an increased force during RA
contraction is very likely to produce an increased
RV filling pressure. Although RV diastolic proper-
ties were not defined in our study, a possible
abnormal RV compliance might produce changes
in resistance to trans-tricuspid flow affecting peak
A wave velocity and consequently the estimation
of RA ejection force. Thus, increased RV stiffness
might reduce the sensitivity of our data and
obscure some additional information, without sub-
stantially modifying the hemodynamic model
emerging from these findings.TA' ING
EG
NERIA NAPO
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ber 26, 2010Table 6 Multiple regression analysis testing the independent relation of the variables associated with right
atrial ejection force and maximal right atrial volume in the subgroups of patients with mild and in those with
moderate-severe pulmonary artery hypertension
Right atrial ejection force
Mild PAH Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.69 0.00001
Peak E/A ratio transtricuspid flow 0.50 0.0001
Deceleration rate E wave transtricuspid flow (cm/sec2) 0.28 0.03
Multiple R ¼ 0.95 R2 ¼ 0.90 Intercept ¼ 5.4 SEE ¼ 0.8 F ¼ 37.5 p ¼ 0.00002
Moderate-severe PAH Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.66 0.00001
Peak E/A ratio transtricuspid flow 0.36 0.0001
Multiple R ¼ 0.86 R2 ¼ 0.75 Intercept ¼ 6.7 SEE ¼ 1.3 F ¼ 53.6 p ¼ 0.00001
Maximal right atrial volume
Mild PAH Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.88 0.00001
Peak E/A wave ratio transtricuspid flow 0.58 0.00002
Deceleration rate E wave transtricuspid flow (msec) 0.43 0.001
TAPSE (mm) 0.30 0.005
Multiple R ¼ 0.97 R2 ¼ 0.94 Intercept ¼  18.6 SEE ¼ 3.7 F ¼ 39.8 p ¼ 0.00001
Moderate-severe PAH Coeff. b p
RA end-diastolic stress (Kdyne/cm2) 0.74 0.00001
Peak E/A wave ratio transtricuspid flow 0.43 0.00001
RV end-diastolic diameter (outflow tract) (m-mode) 0.35 0.0009
Multiple R ¼ 0.76 R2 ¼ 0.51 Intercept ¼ 24.6 SEE ¼ 9.1 F ¼ 14.1 p ¼ 0.00001
RV ¼ right ventricular.
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 Conclusions
This study provides new information about the
adaptive mechanisms which operate in the right
cardiac chambers in patients with chronic PH. RA
size and systolic function and wall stress signifi-
cantly increase in this condition and parallel signs
of activation of the Frank-Starling mechanism in
both right chambers. Further investigations are
needed to verify whether measurements of RA
ejection force improves the prognostic prediction
obtained by measuring RA dimension in patients
with chronic PH, normal RV dimension and pre-
served systolic function.
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